×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 1: Drug Legislation and Drug Regulation
Session Chair(s)
Diptee A. Gajjar, PhD
Intercontinental Regulatory Strategy Lead
Bristol-Myers Squibb Company, United States
(There will be a 15 minute refreshment break at 10:00AM)
- Development of drug legislation
- Drug regulations in the EU
- Regulatory bodies, structure, responsibilities
- Communication with and between regulatory agencies
- Regulatory guidelines: national and international